Health Library
February 20, 2026
Question on this topic? Get an instant answer from August.
• Many BCBS plans cover Mounjaro for type 2 diabetes, but coverage varies by plan, state, and BCBS affiliate.
• Most plans require prior authorization and may require you to try cheaper medications first through step therapy.
• BCBS does not typically cover Mounjaro for weight loss since it is only approved for type 2 diabetes.
If your doctor mentioned Mounjaro and your first thought was "will my insurance actually pay for this," you are not alone. Mounjaro can cost over $1,500 a month without coverage. That is a real barrier. The answer to whether Blue Cross Blue Shield covers it is not a simple yes or no. It depends on your specific plan, your diagnosis, and where you live.
In most cases, yes. Many BCBS plans include Mounjaro (tirzepatide) on their formulary for treatment of type 2 diabetes. This is only condition Mounjaro is currently approved for by FDA. It was first approved in May 2022 as an add-on to diet and exercise for blood sugar control in adults with type 2 diabetes.
That said, BCBS is not one single company. It is a network of 33 independent regional insurers. Each one sets its own formulary, tier placement, and authorization rules. For example, Anthem BCBS in Ohio lists Mounjaro as a Tier 2 preferred brand. Excellus BCBS covers it in individual and family plans but not in its Medicare plans. Blue Cross Blue Shield of Michigan lists it as a preferred brand with step therapy and quantity limits on its 2026 clinical drug list.
So first step is always to check your specific plan's formulary. You can do this by logging into your BCBS member portal or calling number on back of your insurance card.

BCBS generally does not cover Mounjaro for weight loss. Since drug is approved only for type 2 diabetes, prescribing it for weight management is considered off-label. Most insurers will not pay for off-label use.
If weight management is your goal, ask your doctor about Zepbound. It contains same active ingredient as Mounjaro (tirzepatide) but is specifically approved for chronic weight management. BCBS plans are more likely to cover Zepbound for that purpose, though it still depends on your plan. You can learn more about whether Blue Cross covers Zepbound specifically.
Even when Mounjaro is on your plan's formulary, you will likely need prior authorization before BCBS agrees to pay for it. This means your doctor has to submit paperwork to insurance company showing that prescription is medically necessary.
What BCBS typically wants to see includes a documented diagnosis of type 2 diabetes, lab confirmation like A1C levels, and evidence that you have tried and failed on other less expensive medications first. This last part is called step therapy.
Step therapy means you may need to show that you already tried medications like metformin, a GLP-1 like Ozempic or Trulicity, or another preferred drug before BCBS will approve Mounjaro. Some plans require that you have tried two step-one medications without adequate results. If you are weighing options between those alternatives, it helps to understand how they compare. Here is a closer look at how Trulicity and Ozempic stack up against each other.
If BCBS approves your Mounjaro prescription, your out-of-pocket cost depends on where drug falls on your plan's tier system. On many BCBS plans, Mounjaro sits on Tier 2 as a preferred brand. That usually means a copay somewhere in range of $25 to $100 per month, though some plans use coinsurance instead, where you pay a percentage of drug's cost.
If your plan places Mounjaro on a higher tier or lists it as non-preferred, cost can climb significantly. In that case, you may want to ask your doctor to submit a formulary exception request, arguing that Mounjaro is medically necessary for your specific situation.
You can also stack savings. Eli Lilly offers a manufacturer savings card that can bring your cost down to as little as $25 per month if you have commercial insurance that covers Mounjaro. This card cannot be used with government plans like Medicare, Medicaid, or TRICARE.
If BCBS denies your prior authorization, you have right to appeal. Start with an internal appeal through BCBS. Include detailed documentation from your doctor explaining why Mounjaro is necessary and why alternatives were not effective. If internal appeal fails, most states allow you to request an external review through your state's department of insurance.
Standard prior authorization decisions are typically made within 72 hours. Expedited requests, where a delay could seriously harm your health, must be resolved within 24 hours.
Acting early helps. If your plan is changing its formulary or tier placement for upcoming year, submitting a formulary exception request before change takes effect gives you more time to gather documentation and avoid gaps in treatment.
Many BCBS plans do cover Mounjaro, especially when it is prescribed for type 2 diabetes. But coverage depends heavily on your specific plan, your BCBS affiliate, and whether you meet prior authorization and step therapy requirements. The best thing you can do is check your plan's formulary, talk to your doctor about documentation needed, and submit authorization paperwork early. If you are denied, use your appeal rights. Between savings cards and plan-specific options, there are usually ways to bring cost down to something manageable.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.